Terpineol, a terpene found in cannabis and other plants, reduced depressive-like behavior in mice through a mechanism involving both cannabinoid (CB1/CB2) and dopamine D2 receptors.
Researchers studying cannabis terpenes, neuroscientists investigating endocannabinoid system roles in mood, and those interested in the entourage effect.
Antidepressant effect blocked by both CB1 and CB2 antagonists
What the researchers found
Terpineol at 100-200 mg/kg reduced immobility time in the tail suspension test. Its antidepressant-like effect was blocked by CB1 antagonist AM281, CB2 inverse agonist AM630, and dopamine D2 antagonist sulpiride, but not by caffeine or propranolol. Molecular docking confirmed CB1 and CB2 as promising binding targets.
Why it matters
Terpenes are often overlooked components of cannabis. This study suggests terpineol may contribute to cannabis effects on mood through the endocannabinoid system, supporting the idea that non-cannabinoid compounds in cannabis have biological activity.
The numbers in context
Effective at 100-200 mg/kg oral dose. Effects blocked by CB1, CB2, and D2 receptor antagonists. Not blocked by adenosine or beta-adrenergic antagonists.
How the study worked
LPS-induced depression model in mice with behavioral assessment via tail suspension test and splash test. Pharmacological blocking studies identified receptor mechanisms. Molecular docking analyses predicted binding affinity to cannabinoid and dopamine receptors.
What this study cannot tell us
Animal study using high doses of oral terpineol that may not reflect levels achievable through cannabis use. LPS-induced depression is a simplified model. Molecular docking predictions need experimental validation of direct receptor binding.
How to read the evidence
Preclinical animal study with pharmacological mechanism validation, but high doses and simplified depression model limit translational relevance.
When this study was published
2020 animal study. Early research into terpene-cannabinoid receptor interactions relevant to mood.
The bigger picture
If terpenes like terpineol have antidepressant properties mediated through cannabinoid receptors, this could help explain why different cannabis strains with varying terpene profiles produce different effects on mood.
Questions still open
- Does terpineol reach relevant concentrations in the brain during cannabis use? Would terpineol alone have antidepressant effects in humans? How do terpene profiles interact with cannabinoids to influence mood?
Common questions
What is terpineol?
How does terpineol relate to cannabis?
Read the original research
Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor.
Biomolecules, 10(5)
Citation
Vieira, Graziela; Cavalli, Juliana; Gonçalves, Elaine C D; Braga, Saulo F P; Ferreira, Rafaela S; Santos, Adair R S; Cola, Maíra; Raposo, Nádia R B; Capasso, Raffaele; Dutra, Rafael C. (2020). Antidepressant-Like Effect of Terpineol in an Inflammatory Model of Depression: Involvement of the Cannabinoid System and D2 Dopamine Receptor.. Biomolecules, 10(5). https://doi.org/10.3390/biom10050792
Explore the wider topic
- LGBTQ+ and Cannabis: Higher Use Rates and Recovery
- Cannabis-Induced Psychosis: What It Is, Who's at Risk, and What to Do
- BetterHelp, Cerebral, and Online Therapy: Honest Review
- Quitting Weed with ADHD: Why It Is Harder and What Actually Helps
- Quitting Weed with Depression: What You Need to Know
- Quitting Weed with PTSD: A Practical Guide
- Self-Medicating with Weed: Why It Works Until It Doesn't
- Weed and OCD: Self-Medicating Intrusive Thoughts
- Weed and PTSD: What the Research Actually Shows
- Weed and Childhood Trauma: ACEs, Self-Medication, and the Path to Real Healing
- Weed and Suicidal Thoughts: What You Need to Know